Scientists

Scientists

For science to make the news in a rigorous and attractive way, good sources are needed. Because access to scientific knowledge is a citizen's right.

¿Qué me ofrece?

Help science make headlines with rigour and context. We’ll ask you for feedback on current events in your field and you can participate in the briefings we’ll organise. Need to prepare for an interview? Use our resources on science communication.

Icono
Cómo trabajamos

We’re on the lookout for controversial information about science and we will contact you for your analysis in your area. Do you want to be part of our sources? Contact us. We will not pass your contact details on to anyone else. You can find out more about how we work here.   

Título qué me ofrece
What we offer you
Título cómo trabajamos
How we work

A global report calls for climate change to be recognised as a global health emergency

The 2026 report by The Lancet Countdown on health and climate change reveals that many of the health risks and harms arising from climate change increased more rapidly in the decade since the signing of the Paris Agreement (2016–2025) than in the previous decade (2006–2015). The report, which draws on the work of 146 researchers from more than 30 countries, calls for climate change to be officially recognised and addressed as a global health emergency, and for health to set the agenda for both climate policies and funding priorities.

0

A new drug shows efficacy against advanced endometrial cancer, according to a phase 3 trial

The incidence of and mortality from endometrial cancer (cancer of the uterine lining) have been rising in recent years. When diagnosed at an advanced stage, the prognosis is very poor. A phase 3 clinical trial, coordinated across nearly 30 countries—including Spain—has tested a new treatment for patients whose cancer has progressed following chemotherapy and immunotherapy. The drug combines an antibody designed to target the tumor with a chemotherapy agent that is released once the antibody binds to the tumor cells. The trial, which involved 776 women, showed that the new treatment reduced the risk of cancer progression by 41% and the risk of death by 32% during the study period, compared to standard treatment. The findings are being presented at ESMO, the European Society for Medical Oncology congress currently taking place in Madrid, and are being published simultaneously in The Lancet. 

0

A comprehensive scientific review confirms inequalities in mental health amongst LGBTQIA+ people

There are inequalities in the mental health of LGBTQIA+ people, supported by highly credible scientific evidence, particularly with regard to depression, suicidal behaviour and symptoms related to eating disorders. These are the main findings of a study led by IDIBAPS and published in the journal World Psychiatry, in which the researchers reviewed 22 systematic reviews with meta-analyses — comprising 398 studies on this topic — and analysed the 162 associations relating to mental health.

0

The results of the personalised melanoma vaccine will be presented at the european congress of medical oncology

The administration of intismeran, a personalised therapeutic cancer vaccine developed from each patient’s tumour, together with pembrolizumab immunotherapy following surgery for high-risk melanoma, reduced the risk of recurrence or death by 42 per cent. This phase 3 clinical trial, funded by Moderna and Merck Sharp & Dohme, involved 1,137 patients at very high risk of recurrence who had undergone surgical removal of their melanoma. The companies released preliminary data in August in a press release, and the full results are due to be presented this Saturday at the European Society for Medical Oncology (ESMO) Congress being held in Madrid. Ahead of the announcement, the data were leaked yesterday and the share prices of both companies fell. The scientific paper is due to be published in The New England Journal of Medicine.

0

The summer of 2026 resulted in more than 50,000 heat-related deaths in Europe, two-thirds of which were attributable to climate change

More than 50,000 people died as a result of extreme heat in European towns and cities during the summer of 2026 – the highest figure recorded to date – according to two new studies published in Nature Health. After analysing 854 urban areas across 30 countries (the EU-27, the United Kingdom, Norway and Switzerland), researchers from Imperial College and the London School of Hygiene & Tropical Medicine (United Kingdom) have concluded that climate change resulting from the burning of fossil fuels is responsible for two-thirds of these deaths. The five countries most affected were, in this order, Italy, France, Spain, Germany and the UK. According to these studies, 6,824 people died from heat-related causes in Spain this summer, of whom 77 per cent can be attributed to climate change.

0

A wireless electronic device for treating diabetes and obesity without drugs has been tested in mice

A European team has developed and tested a wireless electronic device—implantable under the skin—in mice to treat diabetes and obesity (diabesity) without the need for medication. The approach is based on electrocatalysis, which converts excess blood glucose into gluconate—a substance that is subsequently excreted by the kidneys. In a proof-of-concept study involving mice with obesity and type 2 diabetes, the device successfully restored normal blood glucose levels. Furthermore, after six weeks of treatment, it was associated with a reduction in both body weight and triglyceride levels. The results are published in Science.  

0

Pregnancies that follow one another in quick succession could accelerate the mother’s biological ageing, according to a study

During pregnancy, women’s biological age accelerates, and this is partially reversed after childbirth. A review published in the journal Trends in Endocrinology & Metabolism suggests that closely spaced pregnancies may prevent the body from recovering fully and could lead to the accumulation of changes associated with biological ageing, with potential long-term consequences for maternal health. Although further studies are still needed to test this hypothesis, the authors suggest that the time elapsed between pregnancies could be a significant factor in women’s ageing.

0

The first case of human infection with the Shamonda virus has been identified in a patient with pre-existing conditions who died in France

The French authorities have announced the first recorded case of human infection with the Shamonda virus. The patient was receiving treatment for a serious illness and died in early October. This virus was first identified in farm animals in Europe this past summer, but had previously been detected in animals outside the continent. It is usually transmitted between animals via the bites of infected midges (Culicoides). It is still unknown how the patient contracted the viral infection and whether this was the direct cause of death. The European Centre for Disease Prevention and Control (ECDC) in a press release has stated that it is monitoring the situation closely.

0

Researchers are investigating whether saltwater marshes in coastal areas can provide protection against flooding

A team from the Netherlands has studied the role that salt marshes might play in protecting coastal areas subject to heavy swells from flooding. To this end, they transported and installed 306 square metres of salt marsh and vegetation in the Delta Flume, one of the world’s largest wave flumes. After 21 hours of exposure to waves up to two metres high, they found that the vegetation can reduce wave height by more than 10 per cent and by up to 50 per cent on low-energy marshy coasts — that is, those where waves reach a maximum of one metre. According to the authors, the restoration and conservation of salt marshes on storm-exposed coasts could be a promising strategy for mitigating the effects of storms. The findings are published in Nature.

0

A quarter of people with depression showed circadian disturbances in an Australian study

Using clinical and genetic data from more than 10,000 Australians with depression, an international team has found that nearly 25 per cent suffered from what they have termed ‘circadian depression’ – a subtype previously proposed by the scientific community that is characterised by disrupted sleep-wake cycles, reduced daytime activity and low energy levels. In the study, those identified as having this form of depression reported an earlier age of onset, more severe clinical features and weight gain during depressive episodes. The authors, whose study is published in The British Journal of Psychiatry, state that these findings “support the apparent validity and potential clinical utility of a circadian subtype of depression as a clinical profile”.

0